Gaush Meditech Ltd Sustainability Profile
Gaush Meditech Ltd., headquartered in China, is a prominent player in the medical technology industry, specialising in innovative healthcare solutions. Founded in [year], the company has established a strong presence in major operational regions across Asia and beyond, focusing on the development and manufacturing of advanced medical devices and diagnostic equipment. With a commitment to quality and innovation, Gaush Meditech offers a diverse range of core products, including [specific products or services], which are distinguished by their cutting-edge technology and user-friendly design. The company has achieved notable milestones, positioning itself as a trusted name in the healthcare sector, recognised for its contributions to improving patient outcomes and enhancing medical practices. Gaush Meditech Ltd. continues to lead the way in medical advancements, striving to meet the evolving needs of healthcare professionals worldwide.
DitchCarbon Score
How does Gaush Meditech Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Gaush Meditech Ltd's score of 24 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Gaush Meditech Ltd's reported carbon emissions
In 2024, Gaush Meditech Ltd reported total carbon emissions of approximately 1,701,970 kg CO2e, a decrease from about 2,322,090 kg CO2e in 2023. The emissions breakdown for 2024 includes 216,760 kg CO2e from Scope 1 and 1,485,210 kg CO2e from Scope 2. In 2023, Scope 1 emissions were 197,770 kg CO2e, while Scope 2 emissions were significantly higher at 2,124,320 kg CO2e. Despite these figures, Gaush Meditech Ltd has not established any specific reduction targets or climate pledges, indicating a lack of formal commitments to reduce emissions. The company does not report Scope 3 emissions, which often encompass indirect emissions from the supply chain and product use. Overall, while Gaush Meditech Ltd has shown a reduction in total emissions from 2023 to 2024, the absence of defined climate commitments or targets suggests an opportunity for further engagement in climate action initiatives.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 136,600 | 000,000 | 000,000 |
| Scope 2 | 1,613,710 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - |
How Carbon Intensive is Gaush Meditech Ltd's Industry?
How Carbon Intensive is Gaush Meditech Ltd's Location?
Gaush Meditech Ltd's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Gaush Meditech Ltd has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
